COVID-19 Genomics UK Consortium
The current COVID-19 pandemic, caused by the SARS-CoV-2 virus, represents a major threat to health. The COVID-19 Genomics UK (COG-UK) consortium has been created to deliver large-scale and rapid whole-genome virus sequencing to local NHS centres and the UK government.
COG-UK is made up of an innovative partnership of NHS organisations, the four Public Health Agencies of the UK, the Wellcome Sanger Institute and over twelve academic partners providing sequencing and analysis capacity.
COG-UK is supported by £20 million funding from the UK Department of Health and Social Care (DHSC), UK Research and Innovation (UKRI) and the Wellcome Sanger Institute, administered by UK Research and Innovation.
News and Blogs
Report 12: 15th October 2020 – COVID-19 Genomics UK (COG-UK) Consortium
COG-UK genome sequence data and tools have been used in more than 120 retrospective and live public health outbreak investigations in the UK since March 2020. Analysis of COG-UK and GISAID data highlights the need to establish a systematic approach for monitoring the appearance and spread of all variants of the SARS-CoV-2 virus
Queen honours three COG-UK scientists in 2020 Birthday List
Three scientists from the COVID-19 Genomics UK (COG-UK) consortium, representing research efforts in England, Scotland and Wales, have been honoured by the Queen for their roles in delivering vital services during the first phase of the COVID-19 global pandemic.
COG-UK Researcher honoured by Queen for COVID-19 work
Professor Emma Thomson, Professor in Infectious Diseases at the MRC-University of Glasgow Centre for Virus Research has been recognised in the Queen’s Birthday Honours. She has been awarded an OBE for services to the NHS during the COVID-19 response.